Literature DB >> 16607392

Racial medicine: here to stay? The success of the International HapMap Project and other initiatives may help to overcome racial profiling in medicine, but old habits die hard.

Katrin Weigmann.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16607392      PMCID： PMC1456889          DOI： 10.1038/sj.embor.7400654

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  18 in total

1.  Genomics. Consensus emerges on HapMap strategy.

Authors:  Jennifer Couzin
Journal:  Science       Date:  2004-04-30       Impact factor: 47.728

Review 2.  How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.

Authors:  Jonathan Kahn
Journal:  Yale J Health Policy Law Ethics       Date:  2004

3.  Are medical and nonmedical uses of large-scale genomic markers conflating genetics and 'race'?

Authors:  Charles N Rotimi
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

4.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

5.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

6.  Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.

Authors:  P Carson; S Ziesche; G Johnson; J N Cohn
Journal:  J Card Fail       Date:  1999-09       Impact factor: 5.712

Review 7.  Implications of biogeography of human populations for 'race' and medicine.

Authors:  Sarah A Tishkoff; Kenneth K Kidd
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

Review 8.  Will tomorrow's medicines work for everyone?

Authors:  Sarah K Tate; David B Goldstein
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

9.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

Review 10.  Race, distributive justice and the promise of pharmacogenomics: ethical considerations.

Authors:  Sandra Soo-Jin Lee
Journal:  Am J Pharmacogenomics       Date:  2003
View more
  5 in total

1.  The structure of common genetic variation in United States populations.

Authors:  Stephen L Guthery; Benjamin A Salisbury; Manish S Pungliya; J Claiborne Stephens; Michael Bamshad
Journal:  Am J Hum Genet       Date:  2007-10-16       Impact factor: 11.025

2.  Science's twin taboos. Is it premature to declare that the debates about the role of religion and race in science are closed?

Authors:  Steve Fuller
Journal:  EMBO Rep       Date:  2008-09-19       Impact factor: 8.807

3.  Pharmacogenomic technologies: a necessary "luxury" for better global public health?

Authors:  Catherine Olivier; Bryn Williams-Jones
Journal:  Global Health       Date:  2011-08-24       Impact factor: 4.185

Review 4.  Race and genetics versus 'race' in genetics: A systematic review of the use of African ancestry in genetic studies.

Authors:  Theresa M Duello; Shawna Rivedal; Colton Wickland; Annika Weller
Journal:  Evol Med Public Health       Date:  2021-06-15

Review 5.  Don't blame the BAME: Ethnic and structural inequalities in susceptibilities to COVID-19.

Authors:  Gillian R Bentley
Journal:  Am J Hum Biol       Date:  2020-07-16       Impact factor: 2.947
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.